What is Science Applications Intl Corp's earnings per share (EPS)?

Science Applications Intl Corp (SAIC) reported diluted earnings per share of $7.70 for fiscal year 2026. This represents a 7.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Science Applications Intl Corp Financials

SAIC

Source SEC Filings (10-K/10-Q) Updated Jan 30, 2026 Currency USD FYE January

This page shows Science Applications Intl Corp (SAIC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SAIC FY2026 2026-04-22

SAIC's main mechanic is turning a steady revenue base into cash with little reinvestment while using leverage to retire shares.

Free cash flow reached $577M even though net income was only $358M, so cash conversion was stronger than accounting profit suggests. With capex only $32M and receivables down to $853M, the business behaved like an asset-light operator rather than a capital-hungry one.

Gross margin stability near 12.0% alongside an operating margin of 7.2% says the core delivery economics stayed fairly steady, while the earnings swing happened lower in the cost stack rather than in direct delivery costs. That matters because a business with stable gross economics is usually easier to steady than one whose underlying work is becoming less profitable.

The balance sheet became more liquid but also more leveraged: the current ratio improved to 1.2x even as debt to equity reached 1.6x. Buybacks of $445M exceeded net income of $358M, so per-share results are being supported by capital returns funded by strong cash flow, not by a larger profit base or meaningful deleveraging.

Financial Health Signals

Financial Profile 44/100

Based on FY2026 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Science Applications Intl Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Science Applications Intl Corp has an operating margin of 7.2%, meaning the company retains $7 of operating profit per $100 of revenue. This results in a moderate score of 40/100, indicating healthy but not exceptional operating efficiency. This is down from 7.5% the prior year.

Growth

Science Applications Intl Corp's revenue declined 2.9% year-over-year, from $7.5B to $7.3B. This contraction results in a growth score of 31/100.

Leverage

Science Applications Intl Corp carries a low D/E ratio of 1.65, meaning only $1.65 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 68/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Science Applications Intl Corp's current ratio of 1.20 is below the typical benchmark, resulting in a score of 19/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Science Applications Intl Corp has a free cash flow margin of 8.0%, earning a moderate score of 42/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Science Applications Intl Corp earns a strong 23.9% return on equity (ROE), meaning it generates $24 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 66/100. This is down from 24.1% the prior year.

Altman Z-Score Grey Zone

2.75

Science Applications Intl Corp scores 2.75, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Neutral

6/9

Science Applications Intl Corp passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.70x

For every $1 of reported earnings, Science Applications Intl Corp generates $1.70 in operating cash flow ($609.0M OCF vs $358.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

4.1x

Science Applications Intl Corp earns $4.1 in operating income for every $1 of interest expense ($521.0M vs $128.0M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$7.3B

YoY-2.9%

5Y CAGR+0.6%

10Y CAGR+5.3%

Science Applications Intl Corp generated $7.3B in revenue in fiscal year 2026. This represents a decrease of 2.9% from the prior year.

EBITDA

$551.0M

YoY-6.3%

5Y CAGR+5.5%

10Y CAGR+8.1%

Science Applications Intl Corp's EBITDA was $551.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 6.3% from the prior year.

Net Income

$358.0M

YoY-1.1%

5Y CAGR+11.4%

10Y CAGR+11.8%

Science Applications Intl Corp reported $358.0M in net income in fiscal year 2026. This represents a decrease of 1.1% from the prior year.

EPS (Diluted)

$7.70

YoY+7.4%

5Y CAGR+16.7%

10Y CAGR+12.0%

Science Applications Intl Corp earned $7.70 per diluted share (EPS) in fiscal year 2026. This represents an increase of 7.4% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$577.0M

YoY+26.0%

5Y CAGR-4.0%

10Y CAGR+10.8%

Science Applications Intl Corp generated $577.0M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 26.0% from the prior year.

Cash & Debt

$182.0M

YoY+287.2%

5Y CAGR-7.0%

10Y CAGR+1.7%

Science Applications Intl Corp held $182.0M in cash against $2.5B in long-term debt as of fiscal year 2026.

Dividends Per Share

$0.37

YoY+0.0%

5Y CAGR+0.0%

10Y CAGR-11.2%

Science Applications Intl Corp paid $0.37 per share in dividends in fiscal year 2026. This represents an increase of 0.0% from the prior year.

Shares Outstanding

43M

YoY-9.0%

5Y CAGR-5.6%

10Y CAGR-0.3%

Science Applications Intl Corp had 43M shares outstanding in fiscal year 2026. This represents a decrease of 9.0% from the prior year.

Margins & Returns

Gross Margin

12.0%

YoY+0.1pp

5Y CAGR+0.8pp

10Y CAGR+2.5pp

Science Applications Intl Corp's gross margin was 12.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is up 0.1 percentage points from the prior year.

Operating Margin

7.2%

YoY-0.4pp

5Y CAGR+1.6pp

10Y CAGR+1.9pp

Science Applications Intl Corp's operating margin was 7.2% in fiscal year 2026, reflecting core business profitability. This is down 0.4 percentage points from the prior year.

Net Margin

4.9%

YoY+0.1pp

5Y CAGR+2.0pp

10Y CAGR+2.2pp

Science Applications Intl Corp's net profit margin was 4.9% in fiscal year 2026, showing the share of revenue converted to profit. This is up 0.1 percentage points from the prior year.

Return on Equity

23.9%

YoY-0.2pp

5Y CAGR+10.6pp

10Y CAGR-8.1pp

Science Applications Intl Corp's ROE was 23.9% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is down 0.2 percentage points from the prior year.

Capital Allocation

R&D Spending

$13.0M

YoY+8.3%

5Y CAGR+16.7%

10Y CAGR+12.5%

Science Applications Intl Corp invested $13.0M in research and development in fiscal year 2026. This represents an increase of 8.3% from the prior year.

Share Buybacks

$445.0M

YoY-20.3%

5Y CAGR+67.3%

10Y CAGR+20.5%

Science Applications Intl Corp spent $445.0M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 20.3% from the prior year.

Capital Expenditures

$32.0M

YoY-11.1%

5Y CAGR-7.0%

10Y CAGR+4.8%

Science Applications Intl Corp invested $32.0M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 11.1% from the prior year.

SAIC Income Statement

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Revenue	$7.3B-2.9%	$7.5B+0.5%	$7.4B-3.4%	$7.7B+4.2%	$7.4B+4.8%	$7.1B
Cost of Revenue	$6.4B-3.0%	$6.6B+0.2%	$6.6B-3.6%	$6.8B+4.3%	$6.5B+4.3%	$6.3B
Gross Profit	$872.0M-2.2%	$892.0M+2.3%	$872.0M-1.8%	$888.0M+3.4%	$859.0M+8.5%	$792.0M
R&D Expenses	$13.0M+8.3%	$12.0M+200.0%	$4.0M+300.0%	$1.0M-75.0%	$4.0M-33.3%	$6.0M
SG&A Expenses	$350.0M+3.2%	$339.0M-9.1%	$373.0M-0.3%	$374.0M+8.7%	$344.0M-2.3%	$352.0M
Operating Income	$521.0M-7.5%	$563.0M-24.0%	$741.0M+47.9%	$501.0M+8.4%	$462.0M+18.5%	$390.0M
Interest Expense	$128.0M+1.6%	$126.0M+5.0%	$120.0M0.0%	$120.0M+14.3%	$105.0M-13.9%	$122.0M
Income Tax	$29.0M-56.1%	$66.0M-53.8%	$143.0M+98.6%	$72.0M-8.9%	$79.0M+31.7%	$60.0M
Net Income	$358.0M-1.1%	$362.0M-24.1%	$477.0M+57.4%	$303.0M+8.6%	$279.0M+33.5%	$209.0M
EPS (Diluted)	$7.70+7.4%	$7.17-19.3%	$8.88+65.1%	$5.38+12.8%	$4.77+34.0%	$3.56

Metric	Q4'26	Q3'26	Q2'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Revenue	$1.8B-1.1%	$1.8B-5.8%	$1.9B-5.0%	$2.0B+8.7%	$1.8B-1.6%	$1.8B-3.7%	$1.9B+1.2%	$1.9B
Cost of Revenue	$1.5B-1.6%	$1.6B-6.8%	$1.7B-4.1%	$1.7B+8.1%	$1.6B-1.6%	$1.6B-4.1%	$1.7B+2.3%	$1.7B
Gross Profit	$221.0M+2.8%	$215.0M+2.9%	$209.0M-11.8%	$237.0M+12.9%	$210.0M-1.4%	$213.0M-0.5%	$214.0M-6.6%	$229.0M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$85.0M+13.3%	$75.0M-15.7%	$89.0M+7.2%	$83.0M+7.8%	$77.0M-9.4%	$85.0M-24.8%	$113.0M+29.9%	$87.0M
Operating Income	$133.0M-4.3%	$139.0M+14.9%	$121.0M-24.4%	$160.0M+19.4%	$134.0M+2.3%	$131.0M+24.8%	$105.0M-26.6%	$143.0M
Interest Expense	$34.0M+9.7%	$31.0M+3.3%	$30.0M-6.3%	$32.0M+3.2%	$31.0M-8.8%	$34.0M+13.3%	$30.0M+11.1%	$27.0M
Income Tax	$14.0M+173.7%	-$19.0M-205.6%	$18.0M-10.0%	$20.0M+5.3%	$19.0M+5.6%	$18.0M+12.5%	$16.0M-23.8%	$21.0M
Net Income	$85.0M-33.1%	$127.0M+86.8%	$68.0M-35.8%	$106.0M+30.9%	$81.0M+5.2%	$77.0M+28.3%	$60.0M-35.5%	$93.0M
EPS (Diluted)	N/A	$2.71+90.8%	$1.42-33.3%	$2.13+34.8%	$1.58+6.8%	$1.48	N/A	$1.76

SAIC Balance Sheet

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Total Assets	$5.4B+2.7%	$5.2B-0.7%	$5.3B-11.9%	$6.0B+4.2%	$5.7B-1.7%	$5.8B
Current Assets	$1.2B+2.7%	$1.1B+5.2%	$1.1B-34.9%	$1.7B+29.7%	$1.3B-10.3%	$1.4B
Cash & Equivalents	$182.0M+287.2%	$47.0M-4.1%	$49.0M-88.4%	$422.0M+653.6%	$56.0M-78.5%	$261.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$853.0M-15.5%	$1.0B+8.0%	$934.0M-6.1%	$995.0M-9.9%	$1.1B+7.9%	$1.0B
Goodwill	$2.9B+3.3%	$2.9B0.0%	$2.9B0.0%	$2.9B-2.1%	$2.9B+4.4%	$2.8B
Total Liabilities	$3.9B+4.0%	$3.7B+6.2%	$3.5B-18.1%	$4.3B+4.6%	$4.1B-3.8%	$4.2B
Current Liabilities	$982.0M-33.4%	$1.5B+27.7%	$1.2B-25.7%	$1.6B+16.4%	$1.3B-4.6%	$1.4B
Long-Term Debt	$2.5B+31.6%	$1.9B-5.9%	$2.0B-14.4%	$2.3B-0.6%	$2.3B-2.0%	$2.4B
Total Equity	$1.5B-0.3%	$1.5B-14.4%	$1.8B+4.0%	$1.7B+3.2%	$1.6B+4.0%	$1.6B
Retained Earnings	$1.5B-0.1%	$1.5B+0.3%	$1.5B+33.8%	$1.1B+27.9%	$870.0M+26.6%	$687.0M

Metric	Q4'26	Q3'26	Q2'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Total Assets	$5.4B+2.9%	$5.2B-0.2%	$5.2B-1.2%	$5.3B+0.5%	$5.3B0.0%	$5.3B-1.2%	$5.3B-6.1%	$5.7B
Current Assets	$1.2B-2.1%	$1.2B+4.9%	$1.1B-1.0%	$1.2B+5.2%	$1.1B+1.1%	$1.1B-3.5%	$1.1B-18.5%	$1.4B
Cash & Equivalents	$182.0M+279.2%	$48.0M+2.1%	$47.0M+2.2%	$46.0M-4.2%	$48.0M-2.0%	$49.0M-47.9%	$94.0M-69.8%	$311.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	$3.0M	N/A
Accounts Receivable	$853.0M-10.3%	$951.0M-5.7%	$1.0B-1.3%	$1.0B+8.0%	$946.0M+1.3%	$934.0M+2.2%	$914.0M-9.5%	$1.0B
Goodwill	$2.9B+3.3%	$2.9B0.0%	$2.9B0.0%	$2.9B0.0%	$2.9B0.0%	$2.9B0.0%	$2.9B0.0%	$2.9B
Total Liabilities	$3.9B+4.6%	$3.7B-0.6%	$3.7B+1.2%	$3.7B+1.0%	$3.6B+3.8%	$3.5B-1.1%	$3.5B-7.9%	$3.8B
Current Liabilities	$982.0M-32.1%	$1.4B-1.8%	$1.5B+10.2%	$1.3B+3.5%	$1.3B+12.0%	$1.2B-0.3%	$1.2B-5.5%	$1.2B
Long-Term Debt	$2.5B+33.8%	$1.8B-1.7%	$1.9B-3.2%	$1.9B-1.6%	$2.0B-1.2%	$2.0B-1.4%	$2.0B-7.8%	$2.2B
Total Equity	$1.5B-1.1%	$1.5B+0.8%	$1.5B-6.6%	$1.6B-0.8%	$1.6B-7.6%	$1.8B-1.5%	$1.8B-2.4%	$1.8B
Retained Earnings	$1.5B-1.1%	$1.5B+0.9%	$1.5B-6.7%	$1.6B+3.3%	$1.6B+4.2%	$1.5B+4.0%	$1.4B+1.3%	$1.4B

SAIC Cash Flow Statement

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Operating Cash Flow	$609.0M+23.3%	$494.0M+24.7%	$396.0M-25.6%	$532.0M+2.7%	$518.0M-31.4%	$755.0M
Capital Expenditures	$32.0M-11.1%	$36.0M+33.3%	$27.0M+8.0%	$25.0M-30.6%	$36.0M-21.7%	$46.0M
Free Cash Flow	$577.0M+26.0%	$458.0M+24.1%	$369.0M-27.2%	$507.0M+5.2%	$482.0M-32.0%	$709.0M
Investing Cash Flow	-$248.0M-608.6%	-$35.0M-111.1%	$314.0M+972.2%	-$36.0M+87.7%	-$292.0M+76.3%	-$1.2B
Financing Cash Flow	-$235.0M+52.8%	-$498.0M+31.3%	-$725.0M-47.1%	-$493.0M-63.8%	-$301.0M-164.9%	$464.0M
Dividends Paid	$70.0M-6.7%	$75.0M-5.1%	$79.0M-4.8%	$83.0M-3.5%	$86.0M-1.1%	$87.0M
Share Buybacks	$445.0M-20.3%	$558.0M+46.1%	$382.0M+43.1%	$267.0M+18.1%	$226.0M+564.7%	$34.0M

Metric	Q4'26	Q3'26	Q2'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Operating Cash Flow	$258.0M+111.5%	$122.0M+22.0%	$100.0M-30.1%	$143.0M+3.6%	$138.0M+40.8%	$98.0M+55.6%	$63.0M-37.6%	$101.0M
Capital Expenditures	$8.0M+14.3%	$7.0M-12.5%	$8.0M-11.1%	$9.0M+50.0%	$6.0M0.0%	$6.0M-45.5%	$11.0M+175.0%	$4.0M
Free Cash Flow	$250.0M+117.4%	$115.0M+25.0%	$92.0M-31.3%	$134.0M+1.5%	$132.0M+43.5%	$92.0M+76.9%	$52.0M-46.4%	$97.0M
Investing Cash Flow	-$11.0M-57.1%	-$7.0M+53.3%	-$15.0M-1600.0%	$1.0M+111.1%	-$9.0M-28.6%	-$7.0M+30.0%	-$10.0M0.0%	-$10.0M
Financing Cash Flow	-$110.0M+3.5%	-$114.0M-21.3%	-$94.0M+35.6%	-$146.0M-11.5%	-$131.0M+3.7%	-$136.0M+49.6%	-$270.0M-104.5%	-$132.0M
Dividends Paid	$17.0M0.0%	$17.0M-10.5%	$19.0M+5.6%	$18.0M-5.3%	$19.0M-5.0%	$20.0M+5.3%	$19.0M0.0%	$19.0M
Share Buybacks	$98.0M-10.9%	$110.0M-22.5%	$142.0M+17.4%	$121.0M-39.8%	$201.0M+95.1%	$103.0M+15.7%	$89.0M-13.6%	$103.0M

SAIC Financial Ratios

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Gross Margin	12.0%+0.1pp	11.9%+0.2pp	11.7%+0.2pp	11.5%-0.1pp	11.6%+0.4pp	11.2%
Operating Margin	7.2%-0.4pp	7.5%-2.4pp	10.0%+3.5pp	6.5%+0.3pp	6.3%+0.7pp	5.5%
Net Margin	4.9%+0.1pp	4.8%-1.6pp	6.4%+2.5pp	3.9%+0.2pp	3.8%+0.8pp	3.0%
Return on Equity	23.9%-0.2pp	24.1%-3.1pp	27.1%+9.2pp	17.9%+0.9pp	17.0%+3.8pp	13.3%
Return on Assets	6.7%-0.3pp	7.0%-2.1pp	9.1%+4.0pp	5.1%+0.2pp	4.9%+1.3pp	3.6%
Current Ratio	1.20+0.4	0.78-0.2	0.95-0.1	1.08+0.1	0.97-0.1	1.03
Debt-to-Equity	1.65+0.4	1.25+0.1	1.13-0.2	1.38-0.1	1.43-0.1	1.52
FCF Margin	8.0%+1.8pp	6.1%+1.2pp	5.0%-1.6pp	6.6%+0.1pp	6.5%-3.5pp	10.1%

Metric	Q4'26	Q3'26	Q2'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Gross Margin	12.6%+0.5pp	12.2%+1.0pp	11.1%-0.9pp	12.0%+0.4pp	11.6%+0.0pp	11.5%+0.4pp	11.2%-0.9pp	12.1%
Operating Margin	7.6%-0.3pp	7.9%+1.4pp	6.5%-1.7pp	8.1%+0.7pp	7.4%+0.3pp	7.1%+1.6pp	5.5%-2.1pp	7.5%
Net Margin	4.9%-2.3pp	7.2%+3.6pp	3.6%-1.7pp	5.4%+0.9pp	4.5%+0.3pp	4.2%+1.0pp	3.1%-1.8pp	4.9%
Return on Equity	5.7%-2.7pp	8.4%+3.9pp	4.5%-2.1pp	6.6%+1.6pp	5.0%+0.6pp	4.4%+1.0pp	3.4%-1.7pp	5.1%
Return on Assets	1.6%-0.9pp	2.4%+1.1pp	1.3%-0.7pp	2.0%+0.5pp	1.5%+0.1pp	1.5%+0.3pp	1.1%-0.5pp	1.6%
Current Ratio	1.20+0.4	0.83+0.1	0.78-0.1	0.87+0.0	0.85-0.1	0.95-0.0	0.98-0.2	1.13
Debt-to-Equity	1.65+0.4	1.22-0.0	1.25+0.0	1.200.0	1.21+0.1	1.130.0	1.13-0.1	1.20
FCF Margin	14.3%+7.8pp	6.5%+1.6pp	4.9%-1.9pp	6.8%-0.5pp	7.3%+2.3pp	5.0%+2.3pp	2.7%-2.4pp	5.1%

Similar Companies

Applied Digital APLD

$10.4B

Ingram Micro Holding Corp. INGM

$7.0B

Parsons PSN

$5.5B

Pony AI Inc. PONY

$4.5B

Verra Mobility Corp VRRM

$2.3B

Frequently Asked Questions

What is Science Applications Intl Corp's annual revenue?

Science Applications Intl Corp (SAIC) reported $7.3B in total revenue for fiscal year 2026. This represents a -2.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Science Applications Intl Corp's revenue growing?

Science Applications Intl Corp (SAIC) revenue declined by 2.9% year-over-year, from $7.5B to $7.3B in fiscal year 2026.

Is Science Applications Intl Corp profitable?

Yes, Science Applications Intl Corp (SAIC) reported a net income of $358.0M in fiscal year 2026, with a net profit margin of 4.9%.

What is Science Applications Intl Corp's EBITDA?

Science Applications Intl Corp (SAIC) had EBITDA of $551.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Science Applications Intl Corp have?

As of fiscal year 2026, Science Applications Intl Corp (SAIC) had $182.0M in cash and equivalents against $2.5B in long-term debt.

What is Science Applications Intl Corp's gross margin?

Science Applications Intl Corp (SAIC) had a gross margin of 12.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Science Applications Intl Corp's operating margin?

Science Applications Intl Corp (SAIC) had an operating margin of 7.2% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Science Applications Intl Corp's net profit margin?

Science Applications Intl Corp (SAIC) had a net profit margin of 4.9% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Does Science Applications Intl Corp pay dividends?

Yes, Science Applications Intl Corp (SAIC) paid $0.37 per share in dividends during fiscal year 2026.

What is Science Applications Intl Corp's return on equity (ROE)?

Science Applications Intl Corp (SAIC) has a return on equity of 23.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Science Applications Intl Corp's free cash flow?

Science Applications Intl Corp (SAIC) generated $577.0M in free cash flow during fiscal year 2026. This represents a 26.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Science Applications Intl Corp's operating cash flow?

Science Applications Intl Corp (SAIC) generated $609.0M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Science Applications Intl Corp's total assets?

Science Applications Intl Corp (SAIC) had $5.4B in total assets as of fiscal year 2026, including both current and long-term assets.

What are Science Applications Intl Corp's capital expenditures?

Science Applications Intl Corp (SAIC) invested $32.0M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does Science Applications Intl Corp spend on research and development?

Science Applications Intl Corp (SAIC) invested $13.0M in research and development during fiscal year 2026.

Does Science Applications Intl Corp buy back shares?

Yes, Science Applications Intl Corp (SAIC) spent $445.0M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

How many shares does Science Applications Intl Corp have outstanding?

Science Applications Intl Corp (SAIC) had 43M shares outstanding as of fiscal year 2026.

What is Science Applications Intl Corp's current ratio?

Science Applications Intl Corp (SAIC) had a current ratio of 1.20 as of fiscal year 2026, which is considered adequate.

What is Science Applications Intl Corp's debt-to-equity ratio?

Science Applications Intl Corp (SAIC) had a debt-to-equity ratio of 1.65 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Science Applications Intl Corp's return on assets (ROA)?

Science Applications Intl Corp (SAIC) had a return on assets of 6.7% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Science Applications Intl Corp's Altman Z-Score?

Science Applications Intl Corp (SAIC) has an Altman Z-Score of 2.75, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Science Applications Intl Corp's Piotroski F-Score?

Science Applications Intl Corp (SAIC) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Science Applications Intl Corp's earnings high quality?

Science Applications Intl Corp (SAIC) has an earnings quality ratio of 1.70x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Science Applications Intl Corp cover its interest payments?

Science Applications Intl Corp (SAIC) has an interest coverage ratio of 4.1x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Science Applications Intl Corp?

Science Applications Intl Corp (SAIC) scores 44 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.